Literature DB >> 21193424

Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies.

Enrico Maria Trecarichi, Mario Tumbarello, Morena Caira, Anna Candoni, Chiara Cattaneo, Domenico Pastore, Rosa Fanci, Annamaria Nosari, Nicola Vianelli, Alessandro Busca, Antonio Spadea, Livio Pagano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21193424      PMCID： PMC3012771          DOI： 10.3324/haematol.2010.036640

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.

Authors:  Mario Tumbarello; Maurizio Sanguinetti; Eva Montuori; Enrico M Trecarichi; Brunella Posteraro; Barbara Fiori; Rita Citton; Tiziana D'Inzeo; Giovanni Fadda; Roberto Cauda; Teresa Spanu
Journal:  Antimicrob Agents Chemother       Date:  2007-03-26       Impact factor: 5.191

3.  Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.

Authors:  Thomas P Lodise; Nimish Patel; Andrea Kwa; Jeffrey Graves; Jon P Furuno; Eileen Graffunder; Ben Lomaestro; Jessina C McGregor
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

Review 4.  Clinical and economic impact of common multidrug-resistant gram-negative bacilli.

Authors:  Christian G Giske; Dominique L Monnet; Otto Cars; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

5.  Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation.

Authors:  Désirée Caselli; Simone Cesaro; Ottavio Ziino; Giulio Zanazzo; Rosaria Manicone; Susanna Livadiotti; Monica Cellini; Stefano Frenos; Giuseppe M Milano; Barbara Cappelli; Maria Licciardello; Chiara Beretta; Maurizio Aricò; Elio Castagnola
Journal:  Haematologica       Date:  2010-03-19       Impact factor: 9.941

6.  Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.

Authors:  Gopi Rangaraj; Bruno P Granwehr; Ying Jiang; Ray Hachem; Issam Raad
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

7.  Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.

Authors:  Enrico M Trecarichi; Mario Tumbarello; Teresa Spanu; Morena Caira; Luana Fianchi; Patrizia Chiusolo; Giovanni Fadda; Giuseppe Leone; Roberto Cauda; Livio Pagano
Journal:  J Infect       Date:  2009-03-09       Impact factor: 6.072

8.  Factors associated with mortality in bacteremic patients with hematologic malignancies.

Authors:  Mario Tumbarello; Teresa Spanu; Morena Caira; Enrico M Trecarichi; Luca Laurenti; Eva Montuori; Luana Fianchi; Fiammetta Leone; Giovanni Fadda; Roberto Cauda; Livio Pagano
Journal:  Diagn Microbiol Infect Dis       Date:  2009-04-02       Impact factor: 2.803
  8 in total
  26 in total

1.  Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients.

Authors:  D Averbuch; E Horwitz; J Strahilevitz; P Stepensky; N Goldschmidt; M E Gatt; M Y Shapira; I B Resnick; D Engelhard
Journal:  Infection       Date:  2013-05-08       Impact factor: 3.553

2.  Ceftolozane-tazobactam therapy for multidrug-resistant Pseudomonas aeruginosa infections in patients with hematologic malignancies and hematopoietic-cell transplant recipients.

Authors:  Morgan Hakki; James S Lewis
Journal:  Infection       Date:  2018-02-19       Impact factor: 3.553

3.  Bacteriological Profile and Antimicrobial Susceptibility Patterns of Gram-Negative Bloodstream Infection and Risk Factors Associated with Mortality and Drug Resistance: A Retrospective Study from Shanxi, China.

Authors:  Nan Shi; Jianbang Kang; Shuyun Wang; Yan Song; Donghong Yin; Xiaoxia Li; Qian Guo; Jinju Duan; Shuqiu Zhang
Journal:  Infect Drug Resist       Date:  2022-07-06       Impact factor: 4.177

4.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Authors:  Diana Averbuch; Christina Orasch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

5.  Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).

Authors:  Diana Averbuch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Christina Orasch; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

6.  Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.

Authors:  C Gudiol; A Albasanz-Puig; J Laporte-Amargós; N Pallarès; A Mussetti; I Ruiz-Camps; P Puerta-Alcalde; E Abdala; C Oltolini; M Akova; M Montejo; M Mikulska; P Martín-Dávila; F Herrera; O Gasch; L Drgona; H Paz Morales; A-S Brunel; E García; B Isler; W V Kern; I Morales; G Maestro-de la Calle; M Montero; S S Kanj; O R Sipahi; S Calik; I Márquez-Gómez; J I Marin; M Z R Gomes; P Hemmatti; R Araos; M Peghin; J L Del Pozo; L Yáñez; R Tilley; A Manzur; A Novo; J Carratalà
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

Review 7.  Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance.

Authors:  E Montassier; E Batard; T Gastinne; G Potel; M F de La Cochetière
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

8.  Acinetobacter baumannii producing OXA-23 detected in the Czech Republic.

Authors:  Marketa Senkyrikova; Vendula Husickova; Magdalena Chroma; Pavel Sauer; Jan Bardon; Milan Kolar
Journal:  Springerplus       Date:  2013-07-02

9.  Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Morena Caira; Anna Candoni; Domenico Pastore; Chiara Cattaneo; Rosa Fanci; Annamaria Nosari; Antonio Spadea; Alessandro Busca; Nicola Vianelli; Teresa Spanu; Livio Pagano
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

Review 10.  Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients.

Authors:  Elisa Balletto; Małgorzata Mikulska
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-07-01       Impact factor: 2.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.